BRIEF-Innocoll says Xaracoll meets primary endpoint in Phase 3 trials in postoperative pain relief

* Announces Xaracoll (Bupivacaine-Collagen bioresorbable

implant) meets primary endpoint in both pivotal phase 3 trials

in postoperative pain relief

Read more